Research Article
Genes Involved in the PD-L1 Pathway Might Associate with Radiosensitivity of Patients with Gastric Cancer
Table 1
Associations of clinical indicators and 13 genes expression levels with total survival.
| | Univariate analysis | Multivariate analysis | HR (95%CI) | values | HR (95%CI) | values |
| Radiotherapy | | | | | Yes | 0.407 (0.255–0.651) | <0.001 | 0.417 (0.245–0.710) | 0.001 | No | 1.0000 | | 1.000 | | Gender | | | | | Male | 1.271 (0.897–1.801) | 0.178 | 1.308 (0.919–1.862) | 0.136 | Female | 1.0000 | | 1.000 | | Age | | | | | ≥60 | 1.361 (0.945–1.96) | 0.097 | 1.402 (0.958–2.053) | 0.084 | <60 | 1.0000 | | 1.000 | | Histologic type | | | | | NOS | 1.199 (0.788–1.823) | 0.397 | 1.274 (0.831–1.954) | 0.264 | DT/MT/SRT | 0.903 (0.555–1.47) | 0.682 | 1.112 (0.682–1.840) | 0.655 | PT/TT | 1.0000 | | 1.000 | | T Stage | | | | | T3/T4 | 1.854 (1.215–2.827) | 0.004 | 1.381 (0.855–2.230) | 0.187 | T1/T2 | 1.0000 | | 1.000 | | M Stage | | | | | M1 | 1.909 (1.165–3.128) | 0.010 | 1.674 (0.999–2.805) | 0.050 | M0 | 1.0000 | | 1.000 | | N stage | | | | | N1/N2/N3 | 1.953 (1.301–2.931) | 0.001 | 1.753 (1.023–3.004) | 0.041 | N0 | 1.0000 | | 1.000 | | Pathological stage | | | | | III/IV | 1.859 (1.309–2.639) | 0.001 | 1.481 (0.897–2.446) | 0.125 | I/II | 1.0000 | | 1.000 | | Targeted therapy | | | | | Yes | 0.680 (0.489–0.946) | 0.022 | 0.894 (0.430–1.861) | 0.765 | No | 1.0000 | | 1.000 | | Chemotherapy | | | | | Yes | 0.703 (0.508–0.973) | 0.034 | 0.804 (0.401–1.610) | 0.537 | No | 1.0000 | | 1.000 | | CD274 | | | | | High | 0.813 (0.588–1.123) | 0.209 | 0.734 (0.524–1.027) | 0.071 | Low | 1.0000 | | 1.000 | | EGFR | | | | | High | 1.098 (0.794–1.518) | 0.573 | 1.209 (0.867–1.686) | 0.262 | Low | 1.0000 | | 1.000 | | RAF1 | | | | | High | 1.046 (0.757–1.445) | 0.786 | 1.249 (0.896–1.741) | 0.190 | Low | 1.0000 | | 1.000 | | MTOR | | | | | High | 0.906 (0.656–1.252) | 0.552 | 1.008 (0.725–1.401) | 0.962 | Low | 1.0000 | | 1.000 | | RPS6KB1 | | | | | High | 1.154 (0.836–1.595) | 0.384 | 1.283 (0.920–1.789) | 0.142 | Low | 1.0000 | | 1.000 | | CHUK | | | | | High | 0.865 (0.625–1.197) | 0.382 | 0.941 (0.676–1.309) | 0.717 | Low | 1.0000 | | 1.000 | | NFKB1 | | | | | High | 0.873 (0.632–1.205) | 0.409 | 1.016 (0.729–1.416) | 0.926 | Low | 1.0000 | | 1.000 | | TRAF6 | | | | | High | 1.268 (0.917–1.753) | 0.151 | 1.358 (0.974–1.893) | 0.071 | Low | 1.0000 | | 1.000 | | FOS | | | | | High | 1.124 (0.813–1.554) | 0.478 | 1.287 (0.923–1.794) | 0.137 | Low | 1.0000 | | 1.000 | | HIF1A | | | | | High | 1.256 (0.909–1.737) | 0.168 | 1.184 (0.838–1.672) | 0.339 | Low | 1.0000 | | 1.000 | | NFATC1 | | | | | High | 1.291 (0.932–1.787) | 0.124 | 1.364 (0.962–1.934) | 0.081 | Low | 1.0000 | | 1.000 | | PIK3CA | | | | | High | 1.196 (0.864–1.656) | 0.280 | 1.228 (0.876–1.722) | 0.233 | Low | 1.0000 | | 1.000 | | HRAS | | | | | High | 0.881 (0.638–1.217) | 0.441 | 0.882 (0.635–1.225) | 0.454 | Low | 1.0000 | | 1.000 | |
|
|
Abbreviations.HR: hazard ratio; NOS: not otherwise specified; DT: diffuse type; MT: mucinous type; SRT: signet ring type; PT: papillary type; TT: tubular type.
|